January 2015 in “프로그램북(구 초록집)” Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.
March 2014 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” Dutasteride 0.5mg was found to be more effective than finasteride 1mg in treating male pattern hair loss, with similar side effects.
February 2014 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” Dutasteride 0.5mg is more effective than finasteride 1mg for treating male pattern baldness.
March 2007 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” Dutasteride helps reduce male pattern hair loss, but may cause side effects like altered libido and erectile dysfunction.
March 2002 in “Hair transplant forum international” Dutasteride's effect on hair loss treatment is uncertain and should be used cautiously.
April 2022 in “Reactions Weekly” 
February 2026 in “Frontiers in Medicine” Oral minoxidil improved hair loss more than oral dutasteride.
June 2022 in “Journal of The European Academy of Dermatology and Venereology” Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.
August 2016 in “Journal of Investigative Dermatology” 24 citations
,
January 2017 in “International Journal of Trichology” 3 citations
,
November 2024 in “Journal of the European Academy of Dermatology and Venereology” April 2026 in “Benha Medical Journal” December 2025 in “Journal of the European Academy of Dermatology and Venereology” July 2025 in “Journal of Investigative Dermatology” May 2025 in “Journal of the European Academy of Dermatology and Venereology” 
August 2023 in “MPPKI (Media Publikasi Promosi Kesehatan Indonesia) : The Indonesia journal of health promotion” The document's conclusion cannot be provided because the document is not available or cannot be parsed.
March 2013 in “European Urology Supplements” August 2022 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” January 2008 in “프로그램북(구 초록집)” 1 citations
,
December 2020 in “The World Journal of Men's Health” February 2026 in “European Urology” May 2025 in “Reactions Weekly” March 2023 in “JAAD case reports” October 2021 in “European urology open science” 
April 2016 in “The Journal of Sexual Medicine” June 2013 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” May 2026 in “Reactions Weekly” The article discusses the potential risks associated with the use of finasteride and dutasteride, particularly focusing on the increased risk of suicide and sexual dysfunction. These medications, commonly used for treating hair loss and benign prostatic hyperplasia, have been linked to adverse psychological effects and persistent sexual side effects. The review highlights the importance of monitoring patients for these risks and suggests that healthcare providers should weigh the benefits against the potential for serious side effects when prescribing these drugs. The article emphasizes the need for further research to better understand the mechanisms behind these adverse effects and to develop strategies for mitigating them.
September 2025 in “Reactions Weekly” June 2025 in “International Journal of Dermatology” September 2017 in “ics.org”